Zydus Lifesciences Board of Directors
Get the latest insights into the leadership at Zydus Lifesciences. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
| Bhadresh K Shah | Non Executive Independent Director |
| Apurva S Diwanji | Non Executive Independent Director |
| Shelina P Parikh | Non Executive Independent Woman Director |
| Akhil Monappa | Non Executive Independent Director |
| Upasana Konidela | Non Executive Independent Woman Director |
| Sharvil P Patel | Managing Director |
| Ganesh N Nayak | Whole Time Director |
| Mukesh M Patel | Non Executive Director |
Zydus Lifesciences FAQs
The board at Zydus Lifesciences consists of experienced professionals, including Dhaval N Soni, Pankaj R Patel, and others, overseeing the company’s strategic and corporate governance.
Directors at Zydus Lifesciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dhaval N Soni is the current chairman at Zydus Lifesciences.
Executive directors at Zydus Lifesciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Zydus Lifesciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Zydus Lifesciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
Zydus Lifesciences Associated Pages
